Critical Care

official impact factor 4.60

Bronchospasm and laryngeal stridor as an adverse effect of oxytocin treatment

David Cabestrero*, Carmen Pérez-Paredes, Ramón Fernández-Cid and Miguel A Arribas

Critical Care 2003, 7:392 doi:10.1186/cc2348

Accesses  

  • Last 30 days: 25 accesses
  • Last 365 days: 284 accesses
  • All time: 4740 accesses